These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2782041)

  • 1. Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrénées, France.
    Berr C; Puel J; Clanet M; Ruidavets JB; Mas JL; Alperovitch A
    Acta Neurol Scand; 1989 Jul; 80(1):46-50. PubMed ID: 2782041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral antibody titers, immunogenetic markers, and their interrelations in multiple sclerosis patients and controls.
    Alpérovitch A; Berr C; Cambon-Thomsen A; Puel J; Dugoujon JM; Ruidavets JB; Clanet M
    Hum Immunol; 1991 Jun; 31(2):94-9. PubMed ID: 2066275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin allotypes and susceptibility to multiple sclerosis. An epidemiological and genetic study in the Hautes-Pyrénées county of France.
    Blanc M; Clanet M; Berr C; Dugoujon JM; Ruydavet B; Ducos SJ; Rascol A; Alpérovitch A
    J Neurol Sci; 1986 Aug; 75(1):1-5. PubMed ID: 3091773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of measles virus and canine distemper virus antibodies, and of childhood infections in multiple sclerosis patients and controls.
    Haile R; Smith P; Read D; Nassim D; Warlow C; Russell WC
    J Neurol Sci; 1982 Oct; 56(1):1-10. PubMed ID: 7143023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis and common viral infections in Iceland.
    Gudmundsdóttir S
    Acta Pathol Microbiol Scand B; 1979 Dec; 87(6):379-84. PubMed ID: 539420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral infection in patients with multiple sclerosis and HLA-DR matched controls.
    Compston DA; Vakarelis BN; Paul E; McDonald WI; Batchelor JR; Mims CA
    Brain; 1986 Apr; 109 ( Pt 2)(2):325-44. PubMed ID: 3456817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographical Heterogeneity of Multiple Sclerosis Prevalence in France.
    Pivot D; Debouverie M; Grzebyk M; Brassat D; Clanet M; Clavelou P; Confavreux C; Edan G; Leray E; Moreau T; Vukusic S; Hédelin G; Guillemin F
    PLoS One; 2016; 11(12):e0167556. PubMed ID: 27936086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective association of multiple sclerosis with infectious mononucleosis.
    Zaadstra BM; Chorus AM; van Buuren S; Kalsbeek H; van Noort JM
    Mult Scler; 2008 Apr; 14(3):307-13. PubMed ID: 18208871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing antibodies to canine distemper and measles virus in multiple sclerosis.
    Cook SD; Dowling PC; Russell WC
    J Neurol Sci; 1979 Mar; 41(1):61-70. PubMed ID: 438844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of viral antibodies in Iranian multiple sclerosis patients.
    Khaki M; Ghazavi A; Ghasami K; Rafiei M; Payani MA; Ghaznavi-Rad E; Mosayebi G
    Neurosciences (Riyadh); 2011 Jul; 16(3):224-8. PubMed ID: 21677611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common infectious agents in multiple sclerosis: a case-control study in children.
    Krone B; Pohl D; Rostasy K; Kahler E; Brunner E; Oeffner F; Grange JM; Gärtner J; Hanefeld F
    Mult Scler; 2008 Jan; 14(1):136-9. PubMed ID: 17942525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk.
    Ahlgren C; Torén K; Odén A; Andersen O
    Eur J Epidemiol; 2009; 24(9):541-52. PubMed ID: 19633994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement dependen cytotoxic antibody activity against measles virus in multiple sclerosis.
    Kratzsch V; Kiessling WR
    J Neurol; 1977 Aug; 216(1):39-46. PubMed ID: 72792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of infectious mononucleosis with multiple sclerosis. A population-based study.
    Ramagopalan SV; Valdar W; Dyment DA; DeLuca GC; Yee IM; Giovannoni G; Ebers GC; Sadovnick AD;
    Neuroepidemiology; 2009; 32(4):257-62. PubMed ID: 19209005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis and delayed mumps.
    Hays P
    Acta Neurol Scand; 1992 Mar; 85(3):200-3. PubMed ID: 1575004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histocompatibility types and measles antibodies in multiple sclerosis.
    Fewster ME; Myers LW; Ellison GW; Walford RL
    J Neurol Sci; 1977 Nov; 34(2):287-96. PubMed ID: 925715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte blast transformation responses and viral antibodies in relation to HLA antigens in multiple sclerosis.
    Ilonen J; Reunanen M; Salmi A; Tiilikainen A
    J Neurol Sci; 1981 Jan; 49(1):117-33. PubMed ID: 6259296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests.
    Leinikki P; Shekarchi I; Iivanainen M; Taskinen E; Holmes KV; Madden D; Sever JL
    J Neurol Sci; 1982 Dec; 57(2-3):249-55. PubMed ID: 6298370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.